3.760USD+3.30%Mkt Cap: 40.82M $P/E: 53.711d ago
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers …
Industry Peers
Medical Instruments & Supplies$142.49BUSDP/E 48.8
$84.67BUSDP/E 34.0
$73.25BUSDP/E 36.1
$44.07BUSDP/E 27.9
$31.69BUSDP/E 42.2
$29.41BUSDP/E 19.6
$25.61BUSDP/E 48.5
$19.82BUSDP/E 67.9
$18.23BUSDP/E 44.9
$18.54BUSDP/E 105.1
$14.74BUSDP/E 83.6
$13.59BUSDP/E 44.2
$14.26BUSDP/E 61.9
$14.15BUSDP/E 10.0
$12.78BUSDP/E 30.0
$12.06BUSD
$8.60BUSDP/E 23.1
$8.38BUSDP/E 165.1
$7.69BUSD
$5.63BUSDP/E 23.0
$5.99BUSDP/E 1931.7
$4.53BUSDP/E 30.5
$4.51BUSDP/E 32.6
$4.46BUSD
$4.39BUSDP/E 65.8
$4.03BUSDP/E 40.3
$4.05BUSDP/E 87.2
$3.67BUSDP/E 16.5
$3.32BUSDP/E 21.4
$3.39BUSDP/E 2759.0
$2.85BUSDP/E 21.9
$2.63BUSD
$2.77BUSD
$2.35BUSDP/E 37.9
$1.95BUSDP/E 36.0
$1.89BUSD
$1.80BUSD
$1.48BUSD
$1.44BUSD
$1.29BUSDP/E 74.9
$1.41BUSD
$1.23BUSD
$1.09BUSD
$752.64MUSDP/E 16.0
$811.83MUSD
$756.96MUSDP/E 14.8
$671.62MUSDP/E 39.2
$660.94MUSDP/E 55.9
$584.44MUSD
$360.76MUSDP/E 21.2
$354.68MUSDP/E 17.1
$272.64MUSD
$245.88MUSDP/E 13.6
$232.03MUSDP/E 422.0
$211.00MUSDP/E 35.6
$228.42MUSDP/E 21.2
$198.25MUSDP/E 23.8
$198.75MUSDP/E 1.8
$194.76MUSD
$188.63MUSDP/E 16.3
$160.12MUSD
$164.06MUSD
$123.68MUSDP/E 39.3
$115.11MUSD
$120.22MUSD
$107.50MUSD
$61.36MUSDP/E 6.4
$59.94MUSD
$48.70MUSD
$41.23MUSDP/E 41.0
$37.15MUSD
$32.43MUSD
$26.84MUSD
$25.35MUSDP/E 176.7
$20.69MUSD
$18.82MUSD
$14.75MUSD
$14.58MUSD
$13.43MUSD
$9.21MUSD
$7.52MUSDP/E 12.9
$7.46MUSD
$5.06MUSD
$4.00MUSD
$465.9KUSD
$138.6KUSD
Indicators:|
Key Statistics
Company
Market Cap40.82M $
Enterprise Value37.77M $
Revenue (TTM)19.12M $
Gross Profit11.63M $
Net Income (TTM)1.19M $
Revenue/Share1.800 USD
Last Price3.760 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees36
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)53.71
P/E (Forward)37.60
PEG—
EV/EBITDA47.04
EV/Revenue1.98
P/S2.13
P/B3.81
EPS (TTM)0.07
EPS (Forward)0.10
52W Range
2.66029% of range6.420
52W High6.420 USD
52W Low2.660 USD
Profitability
Gross Margin61.87%
Oper. Margin1.86%
EBITDA Margin4.20%
Profit Margin6.35%
ROE11.70%
ROA8.75%
Growth
Revenue Growth6.90%
Earnings Growth-80.00%
Cash Flow & Leverage
Operating CF1.65M $
CapEx (TTM)—
FCF Margin-4.04%
FCF Yield-1.89%
Net Debt-3.05M $
Net Debt/EBITDA-3.80
Balance Sheet
Debt/Equity0.10
Current Ratio4.55
Quick Ratio2.98
Book Value/Sh0.9870 USD
Cash/Share0.3700 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJul 10, 2019
Splits
Last Split1:9
Split DateJul 10, 2019
Analyst Consensus
Rating—
Target (Mean)7.000 USD
Upside (mean)+86.2%
Target Range6.000 USD – 8.000 USD
$6.000+86.2% to mean$8.000
# Analysts2
Ownership
Shares Out.10.86M
Float8.82M
Insiders12.87%
Institutions49.64%
Short Interest
Short Ratio2.6d
Short % Float0.48%
Short % Out.0.29%
Shares Short31.81K
Short (prev mo.)25.30K
Technical
SMA 503.419 (+10.0%)
SMA 2004.104 (-8.4%)
Beta1.49
S&P 52W Chg20.25%
Avg Vol (30d)10.96K
Avg Vol (10d)9.56K
Technical Indicators
RSI (14)61.0
MACD0.0752
MACD Signal0.0457
MACD Hist.+0.0294
BB Upper3.798 USD
BB Middle3.444 USD
BB Lower3.090 USD
BB Width20.54%
ATR (14)0.2273 USD
Vol Ratio (20d)1.16x